A murine model of hypertonic saline as a treatment for acute spinal cord injury: Effects on autonomic outcome - Laboratory investigation

Howard Levene, Melanie B. Elliott, John P. Gaughan, Christopher M. Loftus, Ronald F. Tuma, Jack I. Jallo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Object. Spinal cord injury (SCI) continues to be a problem without a definitive cure. Research based on improved understanding of the immunological aspects of SCI has revealed targets for treating and ameliorating the extent of secondary injury. Hypertonic saline (HTS), a substance both easy to create and to transport, has been investigated as an immunologically active material that can be used in a clinically relevant interval after injury. In this pilot study, HTS was investigated in a murine model for its abilities to ameliorate secondary injury after a severe spinal cord contusion. Methods. Female C57Bl/6 mice with severe T8-10 contusion injuries were used as the model subjects. A group of 41 mice were studied in a blinded fashion. Mice received treatments with HTS (HTS, 7.5%) or normal saline solution (NSS, 0.9%) at 2 discreet time points (3 and 24 hours after injury.) A separate group of 9 untreated animals were also used as controls. Animals were assessed for autonomic outcome (bladder function). In a group of 33 mice, histological assessment (cellular infiltration) was also measured. Results. Bladder function was found to be improved significantly in those treated with HTS compared with those who received NSS and also at later treatment times (24 hours) than at earlier treatment times (3 hours). Decreased cellular infiltration in each group correlated with bladder recovery. Conclusions. The increased effectiveness of later administration time of the more osmotically active and immunomodulatory substance (HTS) suggests that interaction with events occurring around 24 hours after injury is critical. These events may be related to the invasion of leukocytes peaking at 8-24 hours postinjury and/or the peak benefit time of subject rehydration.

Original languageEnglish
Pages (from-to)131-138
Number of pages8
JournalJournal of Neurosurgery: Spine
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Spinal Cord Injuries
Wounds and Injuries
Urinary Bladder
Contusions
Fluid Therapy
Sodium Chloride
Leukocytes
Therapeutics
Research

Keywords

  • Bladder
  • Hypertonic saline
  • Mouse
  • Murine
  • Secondary injury
  • Spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Neurology

Cite this

A murine model of hypertonic saline as a treatment for acute spinal cord injury : Effects on autonomic outcome - Laboratory investigation. / Levene, Howard; Elliott, Melanie B.; Gaughan, John P.; Loftus, Christopher M.; Tuma, Ronald F.; Jallo, Jack I.

In: Journal of Neurosurgery: Spine, Vol. 14, No. 1, 01.01.2011, p. 131-138.

Research output: Contribution to journalArticle

Levene, Howard ; Elliott, Melanie B. ; Gaughan, John P. ; Loftus, Christopher M. ; Tuma, Ronald F. ; Jallo, Jack I. / A murine model of hypertonic saline as a treatment for acute spinal cord injury : Effects on autonomic outcome - Laboratory investigation. In: Journal of Neurosurgery: Spine. 2011 ; Vol. 14, No. 1. pp. 131-138.
@article{b692f9abefb74f15882ea35ed36a3f21,
title = "A murine model of hypertonic saline as a treatment for acute spinal cord injury: Effects on autonomic outcome - Laboratory investigation",
abstract = "Object. Spinal cord injury (SCI) continues to be a problem without a definitive cure. Research based on improved understanding of the immunological aspects of SCI has revealed targets for treating and ameliorating the extent of secondary injury. Hypertonic saline (HTS), a substance both easy to create and to transport, has been investigated as an immunologically active material that can be used in a clinically relevant interval after injury. In this pilot study, HTS was investigated in a murine model for its abilities to ameliorate secondary injury after a severe spinal cord contusion. Methods. Female C57Bl/6 mice with severe T8-10 contusion injuries were used as the model subjects. A group of 41 mice were studied in a blinded fashion. Mice received treatments with HTS (HTS, 7.5{\%}) or normal saline solution (NSS, 0.9{\%}) at 2 discreet time points (3 and 24 hours after injury.) A separate group of 9 untreated animals were also used as controls. Animals were assessed for autonomic outcome (bladder function). In a group of 33 mice, histological assessment (cellular infiltration) was also measured. Results. Bladder function was found to be improved significantly in those treated with HTS compared with those who received NSS and also at later treatment times (24 hours) than at earlier treatment times (3 hours). Decreased cellular infiltration in each group correlated with bladder recovery. Conclusions. The increased effectiveness of later administration time of the more osmotically active and immunomodulatory substance (HTS) suggests that interaction with events occurring around 24 hours after injury is critical. These events may be related to the invasion of leukocytes peaking at 8-24 hours postinjury and/or the peak benefit time of subject rehydration.",
keywords = "Bladder, Hypertonic saline, Mouse, Murine, Secondary injury, Spinal cord injury",
author = "Howard Levene and Elliott, {Melanie B.} and Gaughan, {John P.} and Loftus, {Christopher M.} and Tuma, {Ronald F.} and Jallo, {Jack I.}",
year = "2011",
month = "1",
day = "1",
doi = "10.3171/2010.9.SPINE08314",
language = "English",
volume = "14",
pages = "131--138",
journal = "Journal of Neurosurgery: Spine",
issn = "1547-5654",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - A murine model of hypertonic saline as a treatment for acute spinal cord injury

T2 - Effects on autonomic outcome - Laboratory investigation

AU - Levene, Howard

AU - Elliott, Melanie B.

AU - Gaughan, John P.

AU - Loftus, Christopher M.

AU - Tuma, Ronald F.

AU - Jallo, Jack I.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Object. Spinal cord injury (SCI) continues to be a problem without a definitive cure. Research based on improved understanding of the immunological aspects of SCI has revealed targets for treating and ameliorating the extent of secondary injury. Hypertonic saline (HTS), a substance both easy to create and to transport, has been investigated as an immunologically active material that can be used in a clinically relevant interval after injury. In this pilot study, HTS was investigated in a murine model for its abilities to ameliorate secondary injury after a severe spinal cord contusion. Methods. Female C57Bl/6 mice with severe T8-10 contusion injuries were used as the model subjects. A group of 41 mice were studied in a blinded fashion. Mice received treatments with HTS (HTS, 7.5%) or normal saline solution (NSS, 0.9%) at 2 discreet time points (3 and 24 hours after injury.) A separate group of 9 untreated animals were also used as controls. Animals were assessed for autonomic outcome (bladder function). In a group of 33 mice, histological assessment (cellular infiltration) was also measured. Results. Bladder function was found to be improved significantly in those treated with HTS compared with those who received NSS and also at later treatment times (24 hours) than at earlier treatment times (3 hours). Decreased cellular infiltration in each group correlated with bladder recovery. Conclusions. The increased effectiveness of later administration time of the more osmotically active and immunomodulatory substance (HTS) suggests that interaction with events occurring around 24 hours after injury is critical. These events may be related to the invasion of leukocytes peaking at 8-24 hours postinjury and/or the peak benefit time of subject rehydration.

AB - Object. Spinal cord injury (SCI) continues to be a problem without a definitive cure. Research based on improved understanding of the immunological aspects of SCI has revealed targets for treating and ameliorating the extent of secondary injury. Hypertonic saline (HTS), a substance both easy to create and to transport, has been investigated as an immunologically active material that can be used in a clinically relevant interval after injury. In this pilot study, HTS was investigated in a murine model for its abilities to ameliorate secondary injury after a severe spinal cord contusion. Methods. Female C57Bl/6 mice with severe T8-10 contusion injuries were used as the model subjects. A group of 41 mice were studied in a blinded fashion. Mice received treatments with HTS (HTS, 7.5%) or normal saline solution (NSS, 0.9%) at 2 discreet time points (3 and 24 hours after injury.) A separate group of 9 untreated animals were also used as controls. Animals were assessed for autonomic outcome (bladder function). In a group of 33 mice, histological assessment (cellular infiltration) was also measured. Results. Bladder function was found to be improved significantly in those treated with HTS compared with those who received NSS and also at later treatment times (24 hours) than at earlier treatment times (3 hours). Decreased cellular infiltration in each group correlated with bladder recovery. Conclusions. The increased effectiveness of later administration time of the more osmotically active and immunomodulatory substance (HTS) suggests that interaction with events occurring around 24 hours after injury is critical. These events may be related to the invasion of leukocytes peaking at 8-24 hours postinjury and/or the peak benefit time of subject rehydration.

KW - Bladder

KW - Hypertonic saline

KW - Mouse

KW - Murine

KW - Secondary injury

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=78650809143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650809143&partnerID=8YFLogxK

U2 - 10.3171/2010.9.SPINE08314

DO - 10.3171/2010.9.SPINE08314

M3 - Article

C2 - 21142467

AN - SCOPUS:78650809143

VL - 14

SP - 131

EP - 138

JO - Journal of Neurosurgery: Spine

JF - Journal of Neurosurgery: Spine

SN - 1547-5654

IS - 1

ER -